Showing 2651-2660 of 5806 results for "".
Biosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentOptimizing Isotretinoin Treatment: Keys to Successful Prescribing and Management
https://practicaldermatology.com/topics/practice-management/optimizing-isotretinoin-treatment-keys-to-successful-prescribing-and-management/21193/Embraced by the dermatology community, isotretinoin is still considered controversial by some patients. Here are tips on navigating the prescribing process to improve patient comfort and adherence.Musely Aging Repair Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/musely-aging-repair-cream/24033/New in My Practice: Cosmeceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceuticals-3/23826/Liquid Nitrogen Cryotherapy Anesthesia for Botulinum Toxin Injections for Hyperhidrosis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/liquid-nitrogen-cryotherapy-anesthesia-for-botulinum-toxin-injections-for-hyperhidrosis/23687/An accessible but underutilized technique can increase patient comfort.Jawline Contouring Treatment with Injectables
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/jawline-contouring-treatment-with-injectables/23647/Use of injectables can produce jaw-dropping results.Establishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dLashing Out: A New Direction in Lash Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lashing-out-a-new-direction-in-lash-treatment/20743/New eyelash ptosis treatment means no more lash curlers.Bonus and Incentive Programs
https://practicaldermatology.com/topics/practice-management/bonus-and-incentive-programs/20918/Profit-sharing legalities and potential pitfalls.